2 not yet recruiting, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Not yet recruiting 2, Recruiting 1 |
Follow HEPATITIS C (HCV): new trials by email Literature Review of HEPATITIS C (HCV) trials Research Report on HEPATITIS C (HCV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combating Related Epidemics in HCV Cepheid GeneXpert HCV Test, INSTI HIV - 1/2 Antibody, bioLytical Laboratories iStatis Hepatitis B Surface Antigen Test - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV) | Phase 4 | Not yet recruiting | Duke University | 1280 | 2027-01-20 | 2026-11-18 |
| AI-Powered Hepatitis C Single-Encounter Test-and-Treat Epclusa (sofosbuvir and velpatasvir) - HEPATITIS C (HCV) | Phase 4 | Not yet recruiting | Patrick Grace | 35 | 2026-12-01 | 2026-08-28 |
| Implementing Low-Barrier HCV Treatment in a Jail Setting Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Community Health Worker - HEPATITIS C (HCV), Incarceration | Phase 4 | Recruiting | Lifespan | 40 | 2025-06-11 | 2026-02-27 |
Hepatitis C (3) · Acquired Immunodeficiency Syndrome (1) · Hepatitis B (1)
Blood-Borne Infections (3) · Communicable Diseases (3) · Digestive System Diseases (3) · Flaviviridae Infections (3) · Hepatitis (3) · Hepatitis, Viral, Human (3) · Infections (3) · Liver Diseases (3) · RNA Virus Infections (3) · Virus Diseases (3) · DNA Virus Infections (1) · Genital Diseases (1) · HIV Infections (1) · Hepadnaviridae Infections (1) · Immune System Diseases (1)
Sofosbuvir (3) · sofosbuvir-velpatasvir drug combination (3) · velpatasvir (3) · Community Health Workers (1) · sofosbuvir velpatasvir voxilaprevir drug combination (1)
Duke University (1) · Lifespan (1) · Patrick Grace (1)
United States (2)
R34DA061732 (1), U01AI195193 (1)